Advertisement
New Zealand markets closed
  • NZX 50

    11,783.15
    +66.71 (+0.57%)
     
  • NZD/USD

    0.6120
    -0.0003 (-0.05%)
     
  • NZD/EUR

    0.5709
    -0.0000 (-0.00%)
     
  • ALL ORDS

    8,020.60
    -56.30 (-0.70%)
     
  • ASX 200

    7,782.50
    -56.30 (-0.72%)
     
  • OIL

    81.26
    +0.43 (+0.53%)
     
  • GOLD

    2,328.30
    -2.50 (-0.11%)
     
  • NASDAQ

    19,701.13
    +226.51 (+1.16%)
     
  • FTSE

    8,247.79
    -33.76 (-0.41%)
     
  • Dow Jones

    39,112.16
    -299.05 (-0.76%)
     
  • DAX

    18,177.62
    -147.96 (-0.81%)
     
  • Hang Seng

    18,069.75
    -3.15 (-0.02%)
     
  • NIKKEI 225

    39,666.02
    +492.87 (+1.26%)
     
  • NZD/JPY

    97.6830
    +0.0320 (+0.03%)
     

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

HERCULES, Calif., May 23, 2024--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523594442/en/

Contacts

Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com

Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com